Skip to content

Clinical trials

Phase 1 Small Cell Lung Carcinoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1 Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20071
20081
20101
20111
20152
20164
20171
20182
20203
20211
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting3
Terminated3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
AHS Cancer Control Alberta2
AbbVie2
Pfizer2
University Health Network, Toronto2
Amgen1
Bristol-Myers Squibb1
British Columbia Cancer Agency1
EMD Serono Research & Development Institute, Inc.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma24
Carcinoma, Non-Small-Cell Lung8
Lung Neoplasms6
Triple Negative Breast Neoplasms4
Carcinoma, Merkel Cell3
Carcinoma, Renal Cell3
Colorectal Neoplasms3
Endometrial Neoplasms3
Head and Neck Neoplasms3
Melanoma3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.